...
首页> 外文期刊>Cardiovascular Diabetology >Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study
【24h】

Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study

机译:急性冠脉综合征患者经皮冠状动脉介入治疗后,基线血浆纤维蛋白原与血红蛋白A1c和2年主要不良心血管事件相关:单中心,前瞻性队列研究

获取原文
           

摘要

Despite revascularisation, a large proportion of acute coronary syndrome (ACS) patients continue to experience major adverse cardiovascular events (MACEs), which are worsened by diabetes mellitus (DM). Fibrinogen (FIB) is a risk factor for MACEs in coronary artery disease and often elevated in DM. However, the relationships between FIB, glucose metabolism (haemoglobin A1c [HbA1c] and fasting blood glucose [FBG]) and MACEs following percutaneous coronary intervention (PCI) in DM, non-DM or whole patients with ACS remains unknown. A total of 411 ACS patients undergoing PCI were enrolled in this study. We compared baseline FIB levels between DM (n?=?103) and non-DM (n?=?308) patients and divided participants into three groups according to FIB level, i.e. FIB-L, FIB-M and FIB-H, to compare baseline characteristics and MACEs. Linear regression analysis of the relationship between glucose metabolism and FIB, Cox regression, survival and landmark analyses of MACEs were also performed over a median of 27.55?months of follow-up. Patients with DM had higher FIB levels than non-DM patients (3.56?±?0.99?mg/dL vs. 3.34?±?0.80?mg/dL, P??0.05). HbA1c and FBG were significantly positively correlated with FIB in whole and DM patients but not in non-DM patients (all P??0.05). Compared with the FIB-L group, the FIB-M (hazard ratio [HR] 1.797, 95% CI 1.117–2.892, P?=?0.016) and FIB-H (HR 1.664, 95% CI 1.002–2.763, P?=?0.049) groups were associated with higher MACEs in whole; the FIB-M (HR 7.783, 95% CI 1.012–59.854, P?=?0.049) was associated with higher MACEs in DM patients. FIB was not associated with MACEs in non-DM patients. During landmark analysis, FIB showed better predictive value for MACEs after PCI in the first 30?months of follow up than in the subsequent period. In this study from China, FIB was positively associated with glucose metabolism (HbA1c and FBG) in whole and DM populations with ACS. Moreover, elevated baseline FIB levels may be an important and independent predictor of MACEs following PCI, especially amongst those with DM. However, as the follow-up period increased, the baseline FIB levels lost their ability to predict MACEs.
机译:尽管进行了血运重建,但仍有很大一部分急性冠脉综合征(ACS)患者继续经历主要的不良心血管事件(MACE),而糖尿病(DM)会使这些事件恶化。纤维蛋白原(FIB)是冠心病中MACE的危险因素,在DM中通常升高。然而,DM,非DM或整个ACS患者经皮冠状动脉介入治疗(PCI)后,FIB,葡萄糖代谢(血红蛋白A1c [HbA1c]和空腹血糖[FBG])与MACE之间的关系仍然未知。本研究共纳入411名接受PCI的ACS患者。我们比较了DM(n == 103)和非DM(n == 308)患者的基线FIB水平,并根据FIB水平将参与者分为三组,即FIB-L,FIB-M和FIB-H,比较基线特征和MACE。在随访的中位数为27.55个月时,还进行了糖代谢与FIB之间关系的线性回归分析,Cox回归,MACE生存率和界标分析。 DM患者的FIB水平高于非DM患者(3.56±±0.99μmg/ dL vs. 3.34±±0.80μmg/ dL,P << 0.05)。在整个和DM患者中,HbA1c和FBG与FIB显着正相关,而在非DM患者中,则不相关(所有P <0.05)。与FIB-L组相比,FIB-M(危险比[HR] 1.797,95%CI 1.117-2.892,P <=?0.016)和FIB-H(HR 1.664,95%CI 1.002-2.763,P?)。 =?0.049)组与整体上较高的MACE相关; FIB-M(HR 7.783,95%CI 1.012–59.854,P?=?0.049)与DM患者较高的MACE相关。非糖尿病患者中FIB与MACE无关。在具有里程碑意义的分析中,FIB在随访的前30个月中对PCI后的MACE表现出更好的预测价值。在这项来自中国的研究中,FIB与ACS整个人群和DM人群的糖代谢(HbA1c和FBG)呈正相关。此外,基线FIB水平升高可能是PCI后发生MACE的重要且独立的指标,尤其是在DM患者中。但是,随着随访时间的延长,基线FIB水平丧失了预测MACE的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号